Enliven Therapeutics, Inc. ( ELVN) - Stock Earnings
ELVN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
ELVN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -29.7 million USD | — USD |
| 2026Q1 | -23.6 million USD | — USD |
| 2026Q2 | -32.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ELVN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -71.6 million USD | — USD |
| 2024 | -89.0 million USD | — USD |
| 2025 | -103.7 million USD | — USD |
| 2026 Est. | — | — |
ELVN
Price: $40.10
52 week price:
Earnings Per Share: -1.65 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 billion